HEART TECHNOLOGY SECOND QUARTER SALES ALMOST QUADRUPLE TO $14 MIL.
This article was originally published in The Gray Sheet
Executive Summary
HEART TECHNOLOGY SECOND QUARTER SALES ALMOST QUADRUPLE TO $14 MIL. on strength of the Rotablator atherectomy system. "The sharp increase in revenue reflected the continued demand for the Rotablator system in coronary...applications in the U.S. and the international market, as well as the increased production rate realized during the quarter," the firm said.